SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001308179-18-000277
Filing Date
2018-11-21
Accepted
2018-11-21 16:00:23
Documents
16
Period of Report
2018-11-21
Effectiveness Date
2018-11-21

Document Format Files

Seq Description Document Type Size
1 AKORN, INC. - DEF 14A lakrx2018_def14a.htm DEF 14A 599998
2 GRAPHIC arrow.jpg GRAPHIC 1156
3 GRAPHIC check.jpg GRAPHIC 988
4 GRAPHIC check1.jpg GRAPHIC 1152
5 GRAPHIC lakrx_proxycard.jpg GRAPHIC 379095
6 GRAPHIC lakrx_proxycard1.jpg GRAPHIC 377619
7 GRAPHIC lakrx1x1.jpg GRAPHIC 22429
8 GRAPHIC lakrx2x1.jpg GRAPHIC 16758
9 GRAPHIC lakrx3.jpg GRAPHIC 963
10 GRAPHIC lakrx4x1.jpg GRAPHIC 32630
11 GRAPHIC lakrx6x1.jpg GRAPHIC 16758
12 GRAPHIC lakrx16x1.jpg GRAPHIC 156484
13 GRAPHIC lakrx25x1.jpg GRAPHIC 1156
14 GRAPHIC lakrx27x2.jpg GRAPHIC 182496
15 GRAPHIC lakrx29x3.jpg GRAPHIC 64091
16 GRAPHIC uncheck.jpg GRAPHIC 1060
  Complete submission text file 0001308179-18-000277.txt   2331363
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32360 | Film No.: 181198193
SIC: 2834 Pharmaceutical Preparations